Atlas Trials

Short-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric Adenocarcinoma

Clinical trial NCT04523818 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04523818
Sponsor
M.D. Anderson Cancer Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Clinical Stage I Gastric Cancer AJCC v8Clinical Stage IIA Gastric Cancer AJCC v8Clinical Stage III Gastric Cancer AJCC v8Clinical Stage IVA Gastric Cancer AJCC v8Gastric AdenocarcinomaPathologic Stage IB Gastric Cancer AJCC v8Pathologic Stage II Gastric Cancer AJCC v8Pathologic Stage IIA Gastric Cancer AJCC v8Pathologic Stage IIB Gastric Cancer AJCC v8Pathologic Stage III Gastric Cancer AJCC v8Pathologic Stage IIIA Gastric Cancer AJCC v8Pathologic Stage IIIB Gastric Cancer AJCC v8
Start date
2020-08-11
Primary completion
2028-12-31
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.